Elasmogen

EnteroBiotix

This biopharmaceutical company develops orally administered microbial therapeutics for patients with gastrointestinal diseases, including irritable bowel syndrome and blood cancers.

Epsilogen

This company develops immunoglobulin E and A based antibody therapeutics to treat patients with solid tumours and ovarian cancer.

Hummingbird Bioscience

This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.

EpiBiologics

This company develops bispecific antibodies to degrade extracellular proteins for patients with cancer and autoimmune disorders.

SciRhom

This biopharmaceutical company develops monoclonal antibodies targeting iRhom2 to treat patients with autoimmune diseases like rheumatoid arthritis and inflammatory bowel disease.

Alyssum Therapeutics

This company develops B cell-based targeted immunotherapies for patients with solid tumours and complex immunological conditions.

NovalGen

NovalGen develops multi-specific antibody therapies and self-regulating immunotherapies for patients with oncology, autoimmune, haematological, and metabolic disorders.

Solu Therapeutics

This biotechnology company develops antibody-based medicines that target and eliminate disease-driving cells to treat patients with cancer and immunological disorders.